MOSCOW, July 1 (RAPSI) – Russia’s Federal Antimonopoly Service (FAS) supported by law enforcement bodies has initiated the check of three Moscow’s pharma distributors on suspicion of cartel agreement over cancer medication supplies, the watchdog has announced on its website.

The suspects are Euroservice Firm, Pharmstore Company and Lancette joint-stock company.

Concurrently, checks are conducted in various Russian regions where heads of ministers and cancer detection centres are suspected of collusion with the inspected firms, the statement reads.